{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:19:35Z","timestamp":1792718375218,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to clarify risk factors for esophageal candidiasis (EC) in immunocompetent patients in a community hospital. 7736 patients who underwent esophagogastroduodenoscopy at our hospital from April 2012 to July 2018 were enrolled. The relationships between EC and the following factors: age, gender, body mass index, lifestyle, lifestyle-related diseases, medication, and endoscopic findings were analyzed. EC was observed in 184 of 7736 cases (2.4% morbidity rate). Multivariate analysis revealed that significant risk factors for the development of EC were: diabetes mellitus {odds ratio (OR): 1.52}, proton pump inhibitor (PPI) use (OR: 1.69), atrophic gastritis (AG) (OR: 1.60), advanced gastric cancer (OR: 4.66), and gastrectomy (OR: 2.32). When severe EC (Kodsi grade\u2009\u2265\u2009II) was compared to mild EC (grade I), the most significant risk factors were advanced gastric cancer (OR: 17.6) and gastrectomy (OR: 23.4). When considering the risk of AG and PPI use with EC development, the risk increased as follows: AG (OR: 1.59), PPI use (OR: 2.25), and both (OR: 3.13). PPI use, AG, advanced gastric cancer and post-gastrectomy are critical risk factors for the development of EC. We suggest close monitoring for EC development when PPIs are administered to patients with these factors.\n<\/jats:p>","DOI":"10.1038\/s41598-021-00132-w","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T10:04:50Z","timestamp":1634637890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk factors for the development of esophageal candidiasis among patients in community hospital"],"prefix":"10.1038","volume":"11","author":[{"given":"Hideyuki","family":"Ogiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Horibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ibuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"132_CR1","unstructured":"Robertson, K. D. & Mehta, D. Esophageal Candidiasis. in StatPearls (StatPearls Publishing, 2019)."},{"key":"132_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas, P. G. et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin. Infect. Dis. 62, e1\u2013e50 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"132_CR3","doi-asserted-by":"publisher","first-page":"3585136","DOI":"10.1155\/2019\/3585136","volume":"2019","author":"AA Mohamed","year":"2019","unstructured":"Mohamed, A. A., Lu, X. & Mounmin, F. A. Diagnosis and treatment of esophageal candidiasis: Current updates. Can. J. Gastroenterol. Hepatol 2019, 3585136 (2019).","journal-title":"Can. J. Gastroenterol. Hepatol"},{"key":"132_CR4","first-page":"89","volume":"2","author":"JA Vazquez","year":"2010","unstructured":"Vazquez, J. A. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl) 2, 89\u2013101 (2010).","journal-title":"HIV AIDS (Auckl)"},{"key":"132_CR5","doi-asserted-by":"publisher","first-page":"e0133589","DOI":"10.1371\/journal.pone.0133589","volume":"10","author":"Y Takahashi","year":"2015","unstructured":"Takahashi, Y. et al. Long-term trends in esophageal candidiasis prevalence and associated risk factors with or without HIV infection: Lessons from an endoscopic study of 80,219 patients. PLoS ONE 10, e0133589 (2015).","journal-title":"PLoS ONE"},{"key":"132_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MOO.0000000000000199","volume":"23","author":"A O\u2019Rourke","year":"2015","unstructured":"O\u2019Rourke, A. Infective oesophagitis: Epidemiology, cause, diagnosis and treatment options. Curr. Opin. Otolaryngol. Head Neck Surg. 23, 459\u2013463 (2015).","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"132_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/gut.33.6.860","volume":"33","author":"AJ Larner","year":"1992","unstructured":"Larner, A. J. & Lendrum, R. Oesophageal candidiasis after omeprazole therapy. Gut 33, 860\u2013861 (1992).","journal-title":"Gut"},{"key":"132_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s100960050437","volume":"19","author":"A Chocarro Mart\u00ednez","year":"2000","unstructured":"Chocarro Mart\u00ednez, A. et al. Risk factors for esophageal candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 19, 96\u2013100 (2000).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/dote.12354","volume":"29","author":"HW Daniell","year":"2016","unstructured":"Daniell, H. W. Acid suppressing therapy as a risk factor for Candida esophagitis. Dis. Esophagus 29, 479\u2013483 (2016).","journal-title":"Dis. Esophagus"},{"key":"132_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.14740\/gr1019w","volume":"11","author":"Y Nassar","year":"2018","unstructured":"Nassar, Y., Eljabbour, T., Lee, H. & Batool, A. Possible risk factors for Candida esophagitis in immunocompetent individuals. Gastroenterol. Res. 11, 195\u2013199 (2018).","journal-title":"Gastroenterol. Res."},{"key":"132_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MED.0000000000000031","volume":"21","author":"VD Corleto","year":"2014","unstructured":"Corleto, V. D., Festa, S., Di Giulio, E. & Annibale, B. Proton pump inhibitor therapy and potential long-term harm. Curr. Opin. Endocrinol. Diabetes Obes. 21, 3\u20138 (2014).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"132_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0016-5085(76)80347-2","volume":"71","author":"BE Kodsi","year":"1976","unstructured":"Kodsi, B. E., Wickremesinghe, C., Kozinn, P. J., Iswara, K. & Goldberg, P. K. Candida esophagitis: A prospective study of 27 cases. Gastroenterology 71, 715\u2013719 (1976).","journal-title":"Gastroenterology"},{"key":"132_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-019-1136-4","volume":"20","author":"A Ohno","year":"2020","unstructured":"Ohno, A. et al. Endoscopic severe mucosal atrophy indicates the presence of gastric cancer after Helicobacter pylori eradication -analysis based on the Kyoto classification. BMC Gastroenterol. 20, 1\u20137 (2020).","journal-title":"BMC Gastroenterol."},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."},{"key":"132_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3109\/00365529708996514","volume":"32","author":"Y Taguchi","year":"1997","unstructured":"Taguchi, Y. et al. Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis: An ultrastructural study. Scand. J. Gastroenterol. 32, 656\u2013663 (1997).","journal-title":"Scand. J. Gastroenterol."},{"key":"132_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/1756283X15592583","volume":"8","author":"P Katz","year":"2015","unstructured":"Katz, P. et al. Daytime intragastric acid control: Post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors. Ther. Adv. Gastroenterol. 8, 322\u2013330 (2015).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"132_CR17","doi-asserted-by":"publisher","first-page":"e00055-11","DOI":"10.1128\/mBio.00055-11","volume":"2","author":"S Vylkova","year":"2011","unstructured":"Vylkova, S. et al. The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio 2, e00055-11 (2011).","journal-title":"MBio"},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/00000658-197406000-00007","volume":"179","author":"JR Brooks","year":"1974","unstructured":"Brooks, J. R., Smith, H. F. & Pease, F. B. Bacteriology of the stomach immediately following vagotomy: The growth of Candida albicans. Ann. Surg. 179, 859\u2013862 (1974).","journal-title":"Ann. Surg."},{"key":"132_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1046\/j.1365-3083.1996.d01-300.x","volume":"44","author":"L Scaringi","year":"1996","unstructured":"Scaringi, L. et al. Activity inhibition of cytolytic lymphocytes by omeprazole. Scand. J. Immunol. 44, 204\u2013214 (1996).","journal-title":"Scand. J. Immunol."},{"key":"132_CR20","doi-asserted-by":"publisher","first-page":"24540","DOI":"10.1016\/S0021-9258(18)54263-0","volume":"266","author":"GL Lukacs","year":"1991","unstructured":"Lukacs, G. L., Rotstein, O. D. & Grinstein, S. Determinants of the phagosomal pH in macrophages. In situ assessment of vacuolar H(+)-ATPase activity, counterion conductance, and H+ \u2018leak\u2019. J. Biol. Chem. 266, 24540\u201324548 (1991).","journal-title":"J. Biol. Chem."},{"key":"132_CR21","doi-asserted-by":"publisher","first-page":"15963","DOI":"10.1074\/jbc.271.27.15963","volume":"271","author":"A Nanda","year":"1996","unstructured":"Nanda, A. et al. Activation of proton pumping in human neutrophils occurs by exocytosis of vesicles bearing vacuolar-type H+-ATPases. J. Biol. Chem. 271, 15963\u201315970 (1996).","journal-title":"J. Biol. Chem."},{"key":"132_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ijo.2012.62","volume":"37","author":"R Huttunen","year":"2013","unstructured":"Huttunen, R. & Syrj\u00e4nen, J. Obesity and the risk and outcome of infection. Int. J. Obes. 37, 333\u2013340 (2013).","journal-title":"Int. J. Obes."},{"key":"132_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.mycmed.2012.08.001","volume":"22","author":"H Mojazi Amiri","year":"2012","unstructured":"Mojazi Amiri, H., Frandah, W., Colmer-Hamood, J., Raj, R. & Nugent, K. Risk factors of Candida colonization in the oropharynx of patients admitted to an intensive care unit. J. Mycol. M\u00e9dicale 22, 301\u2013307 (2012).","journal-title":"J. Mycol. M\u00e9dicale"},{"key":"132_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","volume":"336","author":"I Forgacs","year":"2008","unstructured":"Forgacs, I. & Loganayagam, A. Overprescribing proton pump inhibitors. BMJ 336, 2\u20133 (2008).","journal-title":"BMJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00132-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:31:58Z","timestamp":1670085118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00132-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00132-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20663"}}